News

Santé log2h
Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building. NEW ...
Santé log2h
Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer
The Company is quickly advancing both its Marijuana Breath Test (MBT) with key validation work established in March, and its ...
Santé log5h
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...
Santé log2h
Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations
ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.
Santé log2h
Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories
Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.
Santé log2h
Epilepsy Foundation of America to Present Lifetime Accelerator Award to Orrin Devinsky, M.D.
Internationally acclaimed neurologist and epilepsy researcher Dr. Orrin Devinsky will be honored with the Lifetime Accelerator Award during the Epilepsy Therapies & Diagnostics Development Symposium ...
Santé log2h
Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...
Santé log2h
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
“I also want to thank Dale for his innumerable contributions to Outset during a critical period for the company. The experience, guidance and insights he brought to the board will have a lasting ...
Santé log2h
Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD
Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...
Santé log2h
The Dwayne Andrews Glioblastoma Research Grant Awarded to Dr. Jeremy Brown, Dalhousie University
The Dwayne Andrews Glioblastoma Research Grant has been made possible through the generous support of the Auto|One Group and The Andrews Family.
Santé log2h
Autonomix CEO Brad Hauser to Present at Virtual Investor’s Closing Bell Event
THE WOODLANDS, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted ...
Santé log2h
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
The DBC conference connects emerging growth issuers across multiple sectors with institutional investors. Company representatives will be participating in one-on-one meetings to introduce institutions ...